Cummings, Sanders Seek Answers on Drug Companies' Apparent Obstruction of Congressional Investigation Into Generic Drug Price Increases
August 14, 2019
August 14, 2019
WASHINGTON, Aug. 14 -- Rep. Elijah E. Cummings, D-Maryland, chairman of the House Oversight and Reform Committee, issued the following news release:
Rep. Elijah E. Cummings (D-MD), the Chairman of the House Committee on Oversight and Reform, and Sen. Bernie Sanders (I-VT), Ranking Member of the Senate Budget Committee, sent letters to Heritage Pharmaceuticals, Mylan N.V., and Teva Pharmaceutical Industries Ltd. renewing a 2014 document request about the companies' pricing of generic . . .
Rep. Elijah E. Cummings (D-MD), the Chairman of the House Committee on Oversight and Reform, and Sen. Bernie Sanders (I-VT), Ranking Member of the Senate Budget Committee, sent letters to Heritage Pharmaceuticals, Mylan N.V., and Teva Pharmaceutical Industries Ltd. renewing a 2014 document request about the companies' pricing of generic . . .